Title: Asthma Drugs Market in the US 2015-2019 - Size, Share, Demand, Growth & Opportunities
1Top 10 Diabetes Care Technologies, Devices and
Therapeutics Markets - Growth, Global Share,
Industry Overview, Analysis, Trends Opportunities
and Forecast 2012 - 2020
Asthma Drugs Market in the US 2015-2019 Growth,
Global Share, Industry Overview, Analysis, Trends
Opportunities and Forecast
2Description
Report Overview
About asthma Asthma is a disease that affects
the lungs and is characterized by wheezing,
coughing, breathlessness, and chest tightness. It
is a chronic ailment of the respiratory tract,
which is caused by the obstruction of the flow of
air and bronchospasms, where the muscles around
the respiratory tract swell up. The disease is
believed to be caused by genetic as well as
environmental factors. The American Academy of
Allergy Asthma and Immunology classifies asthma
under four categories exercise-induced asthma,
allergic asthma, occupational asthma, and
childhood asthma. The Asthma and Allergy
Foundation of America classifies asthma into two
categories allergic asthma and non-allergic
asthma. It is an incurable disease but can be
controlled with the help of diagnosis at the
right time, followed by regular therapy. The
asthma drugs market in the US to grow at a CAGR
of 4.64 over the period 2014-2019. Read more
details at http//www.bigmarketresearch.com/asthm
a-drugs-in-the-us-2015-2019-market
3Key Benefits
Summery
Covered in this report Asthma Drugs Market in
the US, report covers the present scenario and
the growth prospects of the asthma drugs market
in the US for the period 2015-2019. To calculate
the market size, the report considers the revenue
generated from the sale of various classes of
drugs used to treat asthma, which include
Bronchodilators Leukotriene antagonists Mast
cell stabilizers Immunosuppressants
Combination of LABAICS Asthma Drugs Market in
the US 2015-2019, has been prepared based on an
in-depth market analysis with inputs from
industry experts. The report covers the market
landscape and its growth prospects in the coming
years. The report also includes a discussion of
the key vendors operating in this market.
4Key Audiences
Key vendors AstraZeneca F. Hoffmann-La
Roche GlaxoSmithKline Merck Other prominent
vendors Abbott Laboratories Addex
Therapeutics Alkermes AstraZeneca Aurobindo
Pharma Avanir Pharmaceuticals Cerecor
Chugai Pharmaceutical Dart NeuroScience Dr.
Reddy's Laboratories Edgemont Pharmaceuticals
E-Therapeutics
5Table Of Contents
Company Profile
Market driver Rise in disease prevalence For
a full, detailed list, view our report Market
challenge Unknown disease etiology For a
full, detailed list, view our report Market
trend Popularity of combination therapies For
a full, detailed list, view our report
6Table Of Contents
Key Audiences
Key questions answered in this report What
will the market size be in 2019 and what will the
growth rate be? What are the key market
trends? What is driving this market? What are
the challenges to market growth? Who are the
key vendors in this market space? What are the
market opportunities and threats faced by the key
vendors? What are the strengths and weaknesses
of the key vendors? Enquire about report
http//www.bigmarketresearch.com/report-enquiry/25
0568
7Get Full Information At http//www.bigmarketrese
arch.com/asthma-drugs-in-the-us-2015-2019-market